PER 0.00% 10.0¢ percheron therapeutics limited

anp an inherent risk, page-66

  1. 14,914 Posts.
    No matter how you look at it, you can't deny that ANP have taken a big step forward with successfull phase 1 trials.

    If that means it is now trying to find equalibrium or fair value and it doesn't go any higher until the next announcement, then that's fine by me.

    ANP started running at around 1.2c and ran to 3.9c post announcement. It's never this simple, but if you divide the rise by 2, one could make a big assumption that fair value is probably somewhere in the middle which is around 2.5c

    If it hovers around 2.5c until the next announcement with a bit of volatility, then I'll be a happy camper.

    All you downrampers cannot take away this most recent announcment and the fact that it has added a lot more value to the company.
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.